Clinical Trial Details
EORTC-06991
Back to Clinical Trials Database
The value of high dose versus standard dose Ara-c during induction and IL-2 after intensive consolidation/autologous stem cell transplantation in patients (age 15-60 yrs) with acute myelogenous leukemia. A randomized phase III trial of the EORTC and GIMEMA Leukemia Cooperative Groups (AML-12).
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 03-Sep-1999 Date Step1 close: 11-Jan-2008 Date Step2 close: 30-Jun-2008 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 1000 - All Groups: 2000 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00004128 |
NCT number | NCT00004128 |